The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ChemoCentryx, Inc(NASDAQ:CCXI) 
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It develops Avacopan, an orally administered selective complement 5a receptor inhibito...
Website: http://www.chemocentryx.com
Founded: 1996
Full Time Employees: 133 (May 2021)
Sector: Healthcare
Industry: Biotechnology
ChemoCentryx Days Payable Outstanding ttm (DPO)
ChemoCentryx Days Receivable Outstanding ttm (DSO)
ChemoCentryx Days Inventory Outstanding ttm (DIO)
ChemoCentryx Op Cashflow Per Share ttm
ChemoCentryx Free Cashflow Per Share ttm
ChemoCentryx Cash Per Share ttm
ChemoCentryx P/S ratio ttm
ChemoCentryx (GAAP) P/E ratio ttm
ChemoCentryx P/B ratio ttm
No extra charts and metrics for this ticker.